Orthofix Medical (OFIX) Raw Materials (2011 - 2026)

Orthofix Medical has disclosed Raw Materials across 16 years of filings, most recently posting $24.9 million for Q1 2026.

• Quarterly Raw Materials fell 4.71% year-over-year to $24.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.9 million (down 4.71% YoY) and the FY2025 annual result came in at $22.9 million, down 15.88% from the prior year.
• Raw Materials advanced to $24.9 million in Q1 2026, from $22.9 million in the prior quarter.
• Over five years, Raw Materials peaked at $30.9 million in Q1 2024 and troughed at $11.3 million in Q1 2022.
• A 5-year average of $24.0 million and a median of $26.1 million in 2025 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2022 — Raw Materials surged 119.11% — and 2025, when it dropped 15.88%.
• Tracing OFIX's Raw Materials over 5 years: stood at $17.0 million in 2022, then surged by 66.66% to $28.4 million in 2023, then declined by 4.26% to $27.2 million in 2024, then slipped by 15.88% to $22.9 million in 2025, then increased by 8.82% to $24.9 million in 2026.
• Business Quant data shows OFIX's Raw Materials at $24.9 million in Q1 2026, $22.9 million in Q4 2025, and $24.8 million in Q3 2025.